Erin Fleischer
YOU?
Author Swipe
View article: Successes, lessons learned and recommendations for the future: Experiences from the first year of Ontario’s nirsevimab program for respiratory syncytial virus (RSV) prophylaxis in infants
Successes, lessons learned and recommendations for the future: Experiences from the first year of Ontario’s nirsevimab program for respiratory syncytial virus (RSV) prophylaxis in infants Open
At the conclusion of the 2024/2025 respiratory syncytial virus (RSV) season in Ontario, a panel of healthcare providers who were actively involved in the conduct of the province's first RSV prophylaxis program with nirsevimab in infants, a…
View article: Variations in the Management of Canadian Patients With CFTR Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID)
Variations in the Management of Canadian Patients With CFTR Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID) Open
Background With routine newborn screening for cystic fibrosis (CF) now considered standard of care, the designation of CFTR Related Metabolic Syndrome (CRMS) or CF screen positive, indeterminate diagnosis (CFSPID) has been established. The…
View article: Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel Open
In June 2024, a group of 12 experts in the respiratory syncytial virus (RSV) field representing a cross-section of healthcare provider types who treat and care for pregnant individuals and infants, assembled to discuss the implementation o…
View article: Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF study
Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF study Open
Background Handheld spirometry allows monitoring of lung function at home, of particular importance during the COVID‐19 pandemic. Pediatric studies are unclear on whether values are interchangeable with traditional, clinic‐based spirometry…
View article: 92 Confirmatory genetic testing for all CF screen positive newborns: a 12-year analysis
92 Confirmatory genetic testing for all CF screen positive newborns: a 12-year analysis Open
Background Cystic fibrosis (CF) is an autosomal recessive disease that can present with multisystem manifestations based on mutations in the CF transmembrane regulator (CFTR) gene. Screening for CF was added to the Newborn Screening Ontari…
View article: The Transitions to Long-term In Home Ventilator Engagement Study (Transitions to LIVE): study protocol for a pragmatic randomized controlled trial
The Transitions to Long-term In Home Ventilator Engagement Study (Transitions to LIVE): study protocol for a pragmatic randomized controlled trial Open
Background overview and rationale We co-developed a multi-component virtual care solution (TtLIVE) for the home mechanical ventilation (HMV) population using the aTouchAway™ platform (Aetonix). The TtLIVE intervention includes (1) virtual …
View article: Estimation of GFR in Patients With Cystic Fibrosis: A Cross-Sectional Study
Estimation of GFR in Patients With Cystic Fibrosis: A Cross-Sectional Study Open
Background: Patients with cystic fibrosis (CF) have frequent infectious complications requiring nephrotoxic medications, necessitating monitoring of renal function. Although adult studies have suggested that cystatin C (CysC)-based estimat…